Pay in 4 interest-free payments of $6.26 Learn more
Ships within 48 hours · Estimated delivery Sep 22 - Sep 27
Uninsured patients who invest in genetic testing early avoid months of trial-and-error dosing, ultimately reducing total medication costs through precision selection
Market Size & Forecast Global Market Value (2025): USD 65.85 Billion Expected Market Value (2033): USD 236.82 Billion Forecast CAGR (20262033): 17.35% Leading Region in 2025: North America Fastest Growing Region: Asia-Pacific Key Market Trends & Insights North America dominated the Glucagon-Like Peptide 1 (GLP-1) Agonists Market with the largest revenue share of 41.38% in 2025, supported by the high prevalence of type 2 diabetes and obesity, strong adoption of innovative GLP-1 therapies, favorable reimbursement frameworks, and the presence of major pharmaceutical manufacturers
We offer affordable self-pay options to make treatment accessible
While the findings on retatrutide are incomplete and its not approved for use in Australia, its becoming increasingly popular on the peptide black market
Leukemic cells seem especially exposed to iron overload with the risk of undergoing ferroptosis
US$ 23.50
US$ 29.27
US$ 29.60
US$ 22.87
US$ 20.51
